Keyphrases
4CMenB
10%
Acute Hospital
14%
Adjusted Odds Ratio
9%
Age Groups
24%
Antibiotic Prescribing
10%
Antibiotic Use
22%
Antibiotics
20%
Antibody Response
9%
Antimicrobial Resistance
26%
Antimicrobial Use
19%
Asymptomatic Infection
9%
Attack Rate
8%
BNT162b2
9%
Care Home Staff
9%
Care Homes
10%
Childhood Vaccination
10%
Clinical Outcomes
8%
Confidence Interval
39%
Conjugate Vaccine
16%
COVID-19
95%
COVID-19 Pandemic
20%
COVID-19 Vaccine
15%
Disease Burden
8%
Disease Control
9%
Epidemiology
18%
Escherichia Coli
9%
Europe
27%
European Countries
12%
European Economic Area
12%
European Union
12%
Excess Mortality
10%
General Practice
8%
Haemophilus Influenzae Type b
23%
Healthcare Workers
33%
Healthcare-associated Infections
12%
Hepatitis B
10%
Hepatitis C
9%
Hepatitis C Virus
11%
Hepatitis C Virus Infection
13%
High Risk
8%
Hospital Admission
16%
Hospitalization
10%
Immunization Programs
8%
Immunogenicity
10%
In Care
9%
Infection Rate
17%
Influenza
33%
Influenza A
11%
Influenza Season
15%
Influenza Vaccination
11%
Influenza-like Illness
9%
Invasive Pneumococcal Disease
15%
Lateral Flow Device
17%
Measles
19%
Measles-mumps-rubella
10%
Meningococcal C Conjugate Vaccine
11%
Meningococcal Disease
18%
Mumps
15%
National Surveillance
13%
Neisseria Meningitidis
12%
Neutralizing Antibodies
9%
Omicron Variant
8%
PCR Test
9%
Pertussis
11%
Point Prevalence Survey
14%
Polymerase Chain Reaction
8%
Primary Care
25%
Primary School children
9%
Public Health
9%
Respiratory Syncytial Virus
21%
Risk Factors
19%
Rubella
9%
SARS-CoV-2 Infection
18%
SARS-CoV-2 Variants
11%
Seasonal Influenza
10%
Seroepidemiology
31%
Serogroup C
8%
Seroprevalence
10%
Serosurvey
8%
Serum Samples
9%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
12%
Siren
16%
Surveillance Data
9%
Surveillance System
10%
Third Dose
11%
Two-dose
9%
United Kingdom
50%
Unvaccinated
9%
Vaccination
46%
Vaccination Campaign
14%
Vaccination Coverage
18%
Vaccination Program
17%
Vaccine Effectiveness
23%
Vaccine Failure
12%
Vaccine Program
8%
Vaccine Uptake
10%
Virus
10%
Wales
61%
Western Europe
9%
World Health Organization
8%
Medicine and Dentistry
Antibiotic Resistance
30%
Antibiotics
15%
Antiinfective Agent
12%
Antiviral Therapy
5%
Arm
6%
Awareness
5%
Beta-Lactamase
5%
Bloodstream Infection
5%
Booster Dose
5%
Carbapenemase
5%
Case-Control Study
5%
Cohort Analysis
10%
Cohort Effect
14%
Conjugate Vaccine
12%
COVID-19
70%
COVID-19 Diagnostics
6%
COVID-19 Vaccine
13%
Cross Sectional Study
12%
Diphtheria Vaccine
5%
Diseases
61%
Emergency Care
5%
Escherichia coli
7%
Evaluation Study
5%
Haemophilus Influenzae Type B
11%
Health Care
8%
Health Care Cost
6%
Healthcare Associated Infection
8%
Hepatitis B
11%
Hepatitis C
13%
Hepatitis C Virus
9%
High Risk Population
5%
Human Respiratory Syncytial Virus
18%
Immune Response
7%
Infection
100%
Influenza A
6%
Influenza A Virus (H1N1)
5%
Influenza A Virus (H3N2)
7%
Influenza B
7%
Influenza Vaccination
9%
Influenza Vaccine
16%
Logistic Regression Analysis
5%
Measles
11%
Men Who Have Sex with Men
5%
Meningococcal Disease
21%
Meningococcus Vaccine
5%
Meta-Analysis
6%
Mortality Rate
5%
Neisseria meningitidis
13%
Neutralizing Antibody
5%
Observational Study
11%
Odds Ratio
10%
Pathogen
13%
Pediatrics
13%
Pertussis
9%
Pneumococcal Infection
5%
Polymerase Chain Reaction
12%
Prevalence
34%
Primary Health Care
24%
Public Health
19%
Randomized Controlled Trial
12%
Reinfection
8%
Respiratory Disease
6%
Respiratory Tract Infection
9%
Seasonal Influenza
10%
Secondary Care
8%
Sepsis
5%
Seroepidemiology
6%
Serotype
26%
Severe Acute Respiratory Syndrome
7%
Severe Acute Respiratory Syndrome Coronavirus 2
75%
Surveillance System
8%
Systematic Review
14%
T Cell
5%
Urinary Tract Infection
5%
Virus
10%
Virus Surveillance
6%